(S)-2-(Boc-Amino) non-8-Enoic Acid CAS 300831-21-4 Purity > 98.0% (GC) ee > 99.0% Paritaprevir Intermediate Factory Featured duab

(S)-2-(Boc-Amino) tsis-8-Enoic Acid CAS 300831-21-4 Purity > 98.0% (GC) ee > 99.0% Paritaprevir Intermediate Factory

Lus piav qhia luv luv:

Lub npe: (S)-2-(Boc-Amino) non-8-Enoic Acid

CAS: 300831-21-4 Nr

Purity:> 98.0% (GC)

yog:> 99.0%

Cov tsos mob: Brown kua

Intermediates ntawm Paritaprevir (CAS: 1216941-48-8)

E-Mail: alvin@ruifuchem.com

Xa email rau peb

Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-(Boc-Amino)non-8-Enoic Acid (CAS: 300831-21-4) with high quality, commercial production. Ruifu Chemical offers a wide range of chiral compounds. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Tshuaj npe	(S)-2-(Boc-Amino) tsis-8-Enoic Acid
Synonyms	(S)-2-(tert-Butoxycarbonylamino) tsis-8-Enoic acid;(S)-2-(Boc-Amino)-8-Nonenoic Acid;(2S)-2-[(2-Methylpropan-2-yl)oxycarbonylamino]non-8-Enoic acid;(2S)-2-{[(tert-Butoxy)carbonyl]amino}non-8-Enoic acid
CAS Nr	300831-21-4
CAT Number	Qauv TSIS MUAJ: RF-CC347
Tshuag xwm txheej	Hauv Tshuag
Molecular Formula	C14H25NO4
Molecular Luj	271.35 Nws
Qhov ntom	1.035 ± 0.06g / cm3
Hom	Ruifu Tshuaj

Specifications:

Yam khoom	Specifications
Qhov tshwm sim	Brown kua
Purity / Analysis Method	> 98.0% (GC)
ee ib	> 99.0%
Test Standard	Enterprise Standard
Kev siv	Intermediates ntawm Paritaprevir (CAS: 1216941-48-8)

Pob & Cia:

Pob: Fluorinated Fwj, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

FAQ:

Daim ntawv thov:

(S)-2-(Boc-Amino) tsis-8-Enoic Acid (CAS: 300831-21-4) tuaj yeem siv los ua ib qho nruab nrab hauv kev sib txuas ntawm Paritaprevir (CAS: 1216941-48-8) thiab lwm yam analogs.Paritaprevir yog ib tug thib ob tiam NS3/4A protease inhibitor, yog ib feem ntawm tag nrho cov qhov ncauj, interferon-dawb kab mob siab kab mob siab C ua ke kev kho mob tsim los ntawm Enanta Pharmaceuticals thiab AbbVie.Cov ntsiav tshuaj tas li ntawm Paritaprevir, Ombitasvir thiab Ritonavir tau coj los ua ke nrog Dasabuvir tau pom zoo rau kev kho mob HCV genotype 1 hauv Tebchaws Meskas thiab EU hauv xyoo 2014, thiab tau pom zoo ntxiv rau kev kho mob genotype 4 chronic HCV tus kab mob tsis muaj kab mob siab los ntawm Asmeskas. FDA pom zoo xyoo 2015.